Daniel Skovronsky
Daniel Skovronsky leads research and development at Eli Lilly and serves as president of Lilly Research Laboratories.
SANOR’s Market Monitors consolidate company announcements, financial reporting and industry developments into a source-linked view of healthcare markets, their participants and their commercial activity.
Sum of reported market sizes. Markets may overlap.
Companies in our market intelligence library.
Last 12 months
Last 12 months
Recent activity covers the past 30 days.
Daniel Skovronsky leads research and development at Eli Lilly and serves as president of Lilly Research Laboratories.
David Ricks leads Eli Lilly as chair and chief executive officer.